Although enormous efforts have been made to restore dystrophin expression in DMD patients through different approaches, such as gene and cell therapies, it has been proposed that fibrosis is an important barrier to the success of these approaches [9,21,56-58]. The gene discussed is DMD; the disease is Duchenne muscular dystrophy.